Dataset from A Randomized, Double-blind, Parallel-group, 26-week Study Comparing the Efficacy and Safety of Indacaterol (Onbrez® Breezhaler® 150 mcg o.d.) With Salmeterol/Fluticasone Propionate (Seretide® Accuhaler® 50 mcg/500 mcg b.i.d.) in Patients With Moderate Chronic Obstructive Pulmonary Disease

The purpose of this study is to compare the effectiveness and safety of indacaterol with salmeterol /fluticasone propionate treatment in patients with moderate chronic obstructive pulmonary disease who, on entry to the study are being treated with salmeterol /fluticasone propionate.

本研究旨在对比茚达特罗（indacaterol）与沙美特罗/丙酸氟替卡松（salmeterol/fluticasone propionate）两种疗法的有效性与安全性，研究对象为入组时正接受沙美特罗/丙酸氟替卡松治疗的中度慢性阻塞性肺疾病（chronic obstructive pulmonary disease）患者。